CD8A and cancer: The counts per mm2 of CD3+, CD8+, Foxp3+, and PD-L1+ cells in CAC patients were significantly lower than those in sporadic cancer patients according to both the phenotyping method (Fig. 1) and the double positivity scoring method (Fig. 2) (all, p < 0.01).